NCT03565029View on ClinicalTrials.gov

Total Neoadjuvant Treatment Without Surgery For Locally Advanced Rectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

October 31, 2022

Study Completion Date

December 20, 2023

Conditions
Colo-rectal Cancer
Interventions
DRUG

XELOX

Capecitabine and Oxaliplatin (4x cycles)

RADIATION

Radiotherapy

Pelvic radiotherapy

Trial Locations (1)

20162

ASST GOM Niguarda, Milan

All Listed Sponsors
lead

Niguarda Hospital

OTHER

NCT03565029 - Total Neoadjuvant Treatment Without Surgery For Locally Advanced Rectal Cancer | Biotech Hunter | Biotech Hunter